UTRN and Duchenne muscular dystrophy: Antisense oligomer (AO) mediated exon skipping is a promising therapeutic approach for Duchenne muscular dystrophy (DMD), with rescue of functional dystrophin isoforms demonstrated in mouse and canine models of muscular dystrophy [1–3], including the severely affected utrophin:dystrophin deficient (dko) mouse [4].